Journal of Dementia
Open Access

Chronic traumatic encephalopathy (CTE); Repetitive head trauma; Neurodegenerative disorders; Early onset symptoms; Cognitive impairments; Behavioral changes; Management strategies; Clinical manifestations; Progressive neurodegeneration; Motor dysfunction

Introduction

Chronic Traumatic Encephalopathy (CTE) is a progressive neurodegenerative condition resulting from repetitive head trauma, frequently observed in individuals with a history of multiple concussions, such as athletes in contact sports, military personnel, and those exposed to frequent head impacts. The disorder has garnered increasing attention due to its association with significant cognitive, emotional, and behavioral impairments, which can profoundly affect the quality of life and functional independence of affected individuals. CTE is characterized by the accumulation of hyperphosphorylated tau protein in the brain, leading to neuroinflammation, neuronal damage, and cognitive decline. Early studies primarily focused on the late-stage manifestations of CTE, which include severe memory loss, executive dysfunction, and motor impairment. However, emerging evidence suggests that early onset symptoms can precede these more severe outcomes, manifesting as mood disturbances, irritability, and subtle cognitive impairments. Recognizing and understanding these early signs are crucial for timely diagnosis and intervention [1].

The variability in symptom presentation between youth and adults complicates the clinical understanding of CTE. In youth, symptoms may be less pronounced or attributed to other developmental or psychological issues, making early diagnosis challenging. In contrast, adults with CTE may exhibit more pronounced cognitive and behavioral symptoms, often linked to a history of repetitive trauma. Both early onset and late symptoms of CTE across different age groups. By synthesizing current research findings and clinical observations, we seek to enhance understanding of the disease's progression and underscore the importance of early detection and management strategies. Through this analysis, we hope to contribute to the development of improved diagnostic criteria and intervention approaches, ultimately aiming to mitigate the impact of CTE on affected individuals and their families [2].

Background on chronic traumatic encephalopathy (CTE):

Chronic Traumatic Encephalopathy (CTE) is a neurodegenerative disorder associated with repetitive head trauma, frequently observed in individuals engaged in contact sports, military personnel, and others exposed to frequent head impacts. The condition has gained prominence due to its profound impact on cognitive, emotional, and behavioral functions, significantly affecting the quality of life and daily functioning of those affected.

Pathophysiology of CTE:

CTE is characterized by the accumulation of hyperphosphorylated tau protein, which leads to neuroinflammation and neuronal damage. This pathological process results in progressive cognitive decline and various neuropsychiatric symptoms [3]. Early research focused on the later stages of CTE, which manifest as severe memory impairment, executive dysfunction, and motor disturbances.

Early onset symptoms and diagnostic challenges:

Recent studies highlight that early onset symptoms of CTE, including mood disturbances, irritability, and subtle cognitive impairments, may appear before more severe symptoms develop. These early signs can be challenging to diagnose, as they may overlap with other psychological or developmental issues, particularly in youth. Understanding these early manifestations is crucial for timely intervention.

Variability between youth and adults:

The presentation of CTE symptoms can vary significantly between youth and adults. In youth, early symptoms may be subtle or misattributed to normal developmental changes, making early diagnosis difficult. In contrast, adults may present with more pronounced cognitive and behavioral symptoms, which are often directly linked to their history of repetitive trauma [4].

Objective of the review:

This review aims to provide a comprehensive examination of both early onset and late symptoms of CTE across different age groups. By integrating current research and clinical observations, this review seeks to enhance understanding of the disease's progression and emphasize the importance of early detection and intervention. Our goal is to contribute to the development of improved diagnostic criteria and management strategies to mitigate the impact of CTE on affected individuals and their families [5].

Result and Discussion

Early onset symptoms:

The review of the literature reveals that early onset symptoms of CTE, such as mood disturbances, irritability, and mild cognitive impairments, are increasingly recognized in both youth and adult populations. These symptoms often manifest as changes in behavior and emotional regulation, including increased aggression, depression, and anxiety. Studies indicate that these early signs may precede more severe manifestations of the disease by several years, making them crucial for early diagnosis and intervention [6].

Late symptoms and disease progression:

In the late stages of CTE, symptoms become more pronounced and debilitating. Cognitive impairments escalate to severe memory loss, executive dysfunction, and impaired judgment. Behavioral symptoms may include significant personality changes, increased aggression, and severe mood disorders. Motor symptoms such as tremors and gait disturbances also become more apparent. The progression from early symptoms to late-stage manifestations varies between individuals but generally follows a pattern of increasing severity over time [7].

Variability in symptom presentation:

The review highlights that symptom presentation can vary significantly between youth and adults. In youth, early symptoms are often less pronounced and may be misattributed to other developmental or psychological issues. Adult individuals with a history of repetitive head trauma may experience more noticeable cognitive and behavioral changes, which are often linked directly to their trauma history. This variability underscores the need for age-specific diagnostic approaches and management strategies [8].

Diagnostic approaches and challenges:

Current diagnostic criteria for CTE include neuroimaging techniques and post-mortem analysis. However, early diagnosis remains challenging due to the overlap of early symptoms with other mental health disorders and the lack of definitive biomarkers. Advances in neuroimaging and the identification of potential biomarkers are promising but still in developmental stages. Effective diagnosis often relies on comprehensive clinical evaluations and detailed patient histories.

Discussion

Importance of early detection:

The identification of early onset symptoms is critical for the timely management of CTE. Early intervention may help slow disease progression and improve the quality of life for affected individuals. Given the potential overlap of early symptoms with other conditions, increased awareness among healthcare providers and the development of more sensitive diagnostic tools are essential [9].

Implications for management and treatment:

The progression from early to late-stage symptoms necessitates a multi-faceted management approach. This includes not only symptomatic treatment but also strategies to address underlying neurodegenerative processes. Current treatment options focus on managing symptoms, but further research is needed to develop interventions that can modify the disease course.

Need for further research:

The review underscores the need for continued research into the pathophysiology of CTE and the development of reliable early diagnostic tools. Longitudinal studies tracking individuals with a history of repetitive head trauma are crucial for understanding the disease's progression and improving prevention strategies [10].

Conclusion

This comprehensive review highlights the complex nature of CTE, with significant variations in symptom presentation between youth and adults. Early onset symptoms, though less recognized, are crucial for timely diagnosis and intervention. Advancements in diagnostic techniques and a deeper understanding of the disease’s progression are essential for improving outcomes for individuals affected by CTE.

Acknowledgment

None

Conflict of Interest

None

1. Bestelmeyer PE, Phillips LH, Crombiz C, Benson P, Clair DS (2009) The P300 as a possible endophenotype for schizophrenia and bipolar disorder: Evidence from twin and patient studies. Psychiatry res 169: 212-219.

Google Scholar, Crossref, Indexed at

2. Blasi G, Goldberg TE, Weickert T, Das S, Kohn P, et al. (2006) Brain regions underlying response inhibition and interference monitoring and suppression. Eur J Neurosci 23: 1658-1664.

Google Scholar, Crossref, Indexed at

3. Bleuler E (1958) Dementia praecox or the group of schizophrenias, New York (International

Universities Press) 1958.
Google Scholar

4. Carter CS, Barch DM (2007) Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophr Bull 33: 1131-1137.

Google Scholar, Crossref, Indexed at

5. Chambers CD, Bellgrove MA, Stokes MG, Henderson TR, Garavan H, et al. (2006) Executive “brake failure” following deactivation of human frontal lobe. J Cogn Neurosci 18: 444-455.

Google Scholar, Crossref, Indexed at

6. Aron AR (2011) From reactive to proactive and selective control: developing a richer model for stopping inappropriate responses. Biol psychiatry 69: e55-e68.

Google Scholar, Crossref, Indexed at

7. Badcock JC, Michie PT, Johnson L, Combrinck J (2002) Acts of control in schizophrenia: dissociating the components of inhibition. Psychol Med 32: 287-297.

Google Scholar, Crossref, Indexed at

8. Bannon S, Gonsalvez CJ, Croft RJ, Boyce PM (2002) Response inhibition deficits in obsessive–compulsive disorder. Psychiatry Res 110: 165-174.

Google Scholar, Crossref, Indexed at

9. Bellgrove MA, Chambers CD, Vance A, Hall N, Karamitsios M, et al. (2006) Lateralized deficit of response inhibition in early-onset schizophrenia. Psychol Med 36: 495-505.

Google Scholar, Crossref, Indexed at

10. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP (1992) Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 12: 924-929.

Google Scholar, Crossref, Indexed at